GOLDENWELL BIOTECH, INC. (GWLL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150 300 450 Q3 '24: 399 Q4 '24: 139 Q1 '25: 139 Q2 '25: 0 Q3 '25: 0 Q4 '25: 55 Q1 '26: 55 Q2 '26: 55 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 50 100 150 Q3 '24: 143 Q4 '24: 70 Q1 '25: 70 Q2 '25: 0 Q3 '25: 0 Q4 '25: 12 Q1 '26: 12 Q2 '26: 12 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-150K -100K -50K 0 50K 100K 150K Q3 '24: -118.5K Q4 '24: -123.1K Q1 '25: -130.6K Q2 '25: -111K Q3 '25: -115.8K Q4 '25: -113.3K Q1 '26: -108.2K Q2 '26: -114.8K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-300K -150K 0 150K 300K 450K Q3 '24: -124.8K Q4 '24: -131.4K Q1 '25: -139K Q2 '25: -119.4K Q3 '25: -124.2K Q4 '25: -296.5K Q1 '26: -275.5K Q2 '26: -282.1K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 90 180 270 Q3 '24: 256 Q4 '24: 69 Q1 '25: 69 Q2 '25: 0 Q3 '25: 0 Q4 '25: 43 Q1 '26: 43 Q2 '26: 43 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-150K -100K -50K 0 50K 100K 150K Q3 '24: -116.8K Q4 '24: -123.1K Q1 '25: -126.3K Q2 '25: -19.2K Q3 '25: -29.1K Q4 '25: -22.6K Q1 '26: -3.7K Q2 '26: -110.4K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 35M 70M 105M Q3 '24: 96.4M Q4 '24: 99M Q1 '25: 99M Q2 '25: 99M Q3 '25: 96.4M Q4 '25: 99M Q1 '26: 99M Q2 '26: 99M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q4 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.